Turn $10K Into $23K With These 3 Ultra-Rare Stock Picks

Hunting for a bargain? This group of beaten-down stocks, including HEXO (TSX:HEXO)(NYSE:HEXO), might provide the value you’re looking for.

| More on:
Canadian Dollars

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Hi there, Fools. I’m back to call attention to three stocks at new 52-week lows. Why? Because the big gains in the stock market are made by buying attractive companies:

With the S&P/TSX Composite Index trading near record highs, the three stocks below are ultra-rare bargains for any portfolio. So, if you’re looking to more double your money (or more) in 2020, this is a good place to start your search.

Let’s get to it.

Hexo marks the spot

Leading off our list is cannabis producer HEXO (TSX:HEXO)(NYSE:HEXO), which is down a whopping 70% over the past year and currently trades at 52-week lows of $1.62 per share.

Operational missteps, industry challenges, and liquidity concerns continue to weigh heavily on the stock. In the most recent quarter, EPS of -$0.24 missed estimates by $0.14 even as revenue jumped 154% to $14.5 million.

On the positive side, HEXO now trades at a cheapish price-to-sales ratio of 9.4. Moreover, management seems to be making plenty of progress in reducing costs.

“Cost control combined with our multi-brand approach, an updated strain mix, as well as the introduction of new products, will help us increase our market share and total revenue, leading us towards great results in 2020,” said co-founder and CEO Sebastien St-Louis.

HEXO currently sports an extremely high beta of nearly 5.

Terminal value

Next up, we have coal storage company Westshore Terminals Investment (TSX:WTE), whose shares are off about 24% over the past year and currently trade near 52-week lows of $16.40.

The stock has been pressured by coal volume concerns in recent months, but now might be a prime opportunity to pounce. In the most recent quarter, for example, profits improved to $40 million even as tonnage shipped volumes remained flat.

More important, the company still managed to generate operating cash flow of $64.8 million.

“Based on current information, 2019 throughput volumes are anticipated to be approximately 30.5 million tonnes, at rates higher than 2018 rates,” wrote the company.

Given Westshore’s paltry P/E ratio of 9.3 and healthy dividend yield of 3.4%, betting on that bullishness might make sense.

Caught in the Web

Rounding out our list is hemp-based products specialist Charlotte’s Web Holdings (TSX:CWEB), which is down about 50% over the past year and currently trades at 52-week lows of $8.33 per share at writing.

Stagnating revenue, share dilution, and increased competition in the cannabidiol (CBD) market continue to pressure the stock. In the most recent quarter, for example, EPS of -$0.01 missed estimates by $0.05 while revenue of $25.05 million also failed to meet expectations.

On the bright side, the company’s position in the growing CBD market remains strong, providing long-term oriented Fools an interesting buying opportunity.

“In an increasingly crowded, noisy and confusing CBD market, brands matter, and Charlotte’s Web is the most trusted hemp extract in the world,” said CEO Deanie Elsner.

The stock currently trades at a price-to-sales of 9.7 at writing.

The bottom line

There you have it, Fools: three ice-cold stocks worth checking out.

As always, don’t see them as formal recommendations. Instead, view them as a starting point for more research. Trying to catch a falling knife can be hazardous to your wealth, so plenty of homework is still required.

Fool on.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool owns shares of and recommends Charlotte's Web Holdings. The Motley Fool recommends HEXO. 

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »